Scarica l'app Stockscreener
5.49
3.21%
-0.08
Dopo l'orario di chiusura:
5.32
-0.17
-3.10%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.57
Aprire:
$5.59
Volume 24 ore:
52,677
Relative Volume:
0.02
Capitalizzazione di mercato:
$77.67M
Reddito:
$37.79M
Utile/perdita netta:
$-10.38M
Rapporto P/E:
-7.5205
EPS:
-0.73
Flusso di cassa netto:
$-1.00M
1 W Prestazione:
-18.44%
1M Prestazione:
+16.19%
6M Prestazione:
+317.92%
1 anno Prestazione:
+197.86%
Intervallo 1D:
$5.19
$5.59
Intervallo di 1 settimana:
$4.64
$6.70
Portata 52W:
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Nome
Cumberland Pharmaceuticals Inc
Settore
Telefono
615-255-0068
Indirizzo
2525 WEST END AVENUE, NASHVILLE,, TN
Confronta CPIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
5.49 | 77.67M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
160.05 | 72.14B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 47.64B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.19 | 45.76B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.46 | 18.67B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.36 | 13.96B | 612.78M | -86.37M | -62.91M | -0.87 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2012-11-12 | Reiterato | UBS | Neutral |
| 2011-02-01 | Reiterato | UBS | Neutral |
| 2010-12-16 | Downgrade | UBS | Buy → Neutral |
| 2010-08-17 | Downgrade | Jefferies | Buy → Hold |
| 2010-08-17 | Reiterato | Morgan Joseph | Buy |
| 2010-08-17 | Reiterato | UBS | Buy |
| 2010-05-14 | Reiterato | Morgan Joseph | Buy |
Mostra tutto
Cumberland Pharmaceuticals Inc Borsa (CPIX) Ultime notizie
Burn Pain Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Cumberland Pharma, Janssen R&D, Cephalon - The Globe and Mail
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above 200-Day Moving Average – Here’s Why - Defense World
Earnings call transcript: Cumberland Q4 2024 results show revenue rise By Investing.com - Investing.com Australia
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Rating Upgraded by StockNews.com - Defense World
Cumberland Pharmaceuticals Inc. (CPIX) reports earnings - Quartz
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2024 Earnings Call Transcript - MSN
Cumberland Pharmaceuticals Inc. to Host Earnings Call - ACCESS Newswire
Cumberland Pharma stock soars to 52-week high of $7.25 By Investing.com - Investing.com Canada
Cumberland Pharmaceuticals: Key Insights from Earnings Call - TipRanks
Cumberland Pharma stock soars to 52-week high of $7.25 - Investing.com India
Cumberland Pharmaceuticals Inc (CPIX) Q4 2024 Earnings Call Highlights: Revenue Growth and ... By GuruFocus - Investing.com Canada
Cumberland: Q4 Earnings Snapshot - Midland Daily News
Cumberland Pharmaceuticals Reports Revenue Growth and Strategic Advances - TipRanks
Earnings call transcript: Cumberland Q4 2024 results show revenue rise - Investing.com
Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth - TradingView
Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth -March 04, 2025 at 04:52 pm EST - Marketscreener.com
Cumberland: Q4 Earnings Snapshot -March 04, 2025 at 04:51 pm EST - Marketscreener.com
Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials - BioSpace
Glenmark Pharmaceuticals Acquires & Launches Acetylcysteine Injection In The U.S. - BW Healthcare World
Glenmark acquires Acetylcysteine injection, launches in US market - BusinessLine
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Held Back By Insufficient Growth Even After Shares Climb 117% - Simply Wall St
Investor Network: Cumberland Pharmaceuticals Inc. to Host Earnings Call - ACCESS Newswire
Cumberland Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2024 FINANCIAL RESULTS - Quantisnow
When Will Cumberland Pharmaceuticals Reveal Its 2024 Performance? Key Date for Specialty Pharma Investors - StockTitan
(CPIX) Trading Report - Stock Traders Daily
Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Have A Healthy Balance Sheet? - Simply Wall St
Cumberland Pharma stock soars to 52-week high of $6.43 By Investing.com - Investing.com South Africa
Cumberland Pharma stock soars to 52-week high of $6.43 - Investing.com
Cumberland Pharmaceuticals' Pneumonia Injection Receives Approval in China -February 18, 2025 at 08:19 am EST - Marketscreener.com
VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA - Finansavisen
Corneal Ulcer Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, NDA Approval, Prevalence, Incidence, Therapies, and Companies by DelveInsight - The Globe and Mail
Short Interest in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Decreases By 56.3% - MarketBeat
Cumberland Pharmaceuticals Inc. Receives Notification from the U.S. Food and Drug Administration - Marketscreener.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Coverage Initiated at StockNews.com - MarketBeat
Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Pass Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Cumberland Pharmaceuticals ups common stock offering - MSN
Cumberland Pharmaceuticals (NASDAQ:CPIX) Now Covered by StockNews.com - Defense World
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
An Analysis of Cumberland Pharmaceuticals Inc (CPIX)’s Potential Price Growth - Knox Daily
Future Outlook And Stock Price Performance For Cumberland Pharmaceuticals Inc (NASDAQ: CPIX) - Marketing Sentinel
Cumberland Pharmaceuticals Inc (CPIX) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
Cumberland Pharmaceuticals Inc (CPIX) Shares Down Despite Recent Market Volatility - The News Heater
Cumberland Pharmaceuticals Inc Azioni (CPIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.73%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):